Method for estimating disease risk from microbiome data using structural equation modeling.

amplicon sequence variants atopic dermatitis human intestinal microbiome latent variables microbiota structural equation modeling

Journal

Frontiers in microbiology
ISSN: 1664-302X
Titre abrégé: Front Microbiol
Pays: Switzerland
ID NLM: 101548977

Informations de publication

Date de publication:
2023
Historique:
received: 05 09 2022
accepted: 09 01 2023
entrez: 13 2 2023
pubmed: 14 2 2023
medline: 14 2 2023
Statut: epublish

Résumé

The relationship between the human gut microbiota and disease is of increasing scientific interest. Previous investigations have focused on the differences in intestinal bacterial abundance between control and affected groups to identify disease biomarkers. However, different types of intestinal bacteria may have interacting effects and thus be considered biomarker complexes for disease. To investigate this, we aimed to identify a new kind of biomarker for atopic dermatitis using structural equation modeling (SEM). The biomarkers identified were latent variables, which are complex and derived from the abundance data for bacterial marker candidates. Groups of females and males classified as healthy participants [normal control (NC) (female: 321 participants, male: 99 participants)], and patients afflicted with atopic dermatitis only [AS (female: 45 participants, male: 13 participants)], with atopic dermatitis and other diseases [AM (female: 75 participants, male: 34 participants)], and with other diseases but without atopic dermatitis [OD (female: 1,669 participants, male: 866 participants)] were used in this investigation. The candidate bacterial markers were identified by comparing the intestinal microbial community compositions between the NC and AS groups. In females, two latent variables (lv) were identified; for lv1, the associated components (bacterial genera) were

Identifiants

pubmed: 36778866
doi: 10.3389/fmicb.2023.1035002
pmc: PMC9909428
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1035002

Informations de copyright

Copyright © 2023 Tokuno, Itoga, Kasuga, Okuma, Hasuko, Masuyama and Benno.

Déclaration de conflit d'intérêts

HT, TI, JK, KH, HM, and KO were employed by Symbiosis Solutions Inc. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Allergy. 2018 Dec;73(12):2314-2327
pubmed: 30325537
Proc Natl Acad Sci U S A. 2014 Feb 11;111(6):2247-52
pubmed: 24390544
Int J Syst Evol Microbiol. 2016 Feb;66(2):768-773
pubmed: 26619944
Appl Microbiol. 1974 May;27(5):961-79
pubmed: 4598229
Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16731-6
pubmed: 18936492
Front Neurol. 2022 Feb 17;13:834403
pubmed: 35250836
BMC Microbiol. 2021 May 27;21(1):156
pubmed: 34044781
J Natl Cancer Inst. 2013 Dec 18;105(24):1907-11
pubmed: 24316595
Nature. 2009 Jan 22;457(7228):480-4
pubmed: 19043404
Nat Commun. 2012;3:1245
pubmed: 23212374
PLoS One. 2013 Jul 02;8(7):e67019
pubmed: 23843979
Circulation. 2018 Nov 27;138(22):2486-2498
pubmed: 30571343
Nat Commun. 2020 Nov 18;11(1):5886
pubmed: 33208745
Biochim Biophys Acta. 2014 Oct;1842(10):1981-1992
pubmed: 24882755
Microbiol Immunol. 2004;48(1):1-6
pubmed: 14734852
J Dermatol. 2021 Feb;48(2):158-167
pubmed: 32860635
Sci Rep. 2019 Jan 22;9(1):287
pubmed: 30670726
Can J Psychiatry. 2005 Feb;50(2):115-22
pubmed: 15807228
Appl Environ Microbiol. 2014 Feb;80(3):928-34
pubmed: 24271166
Nat Commun. 2020 Apr 22;11(1):1922
pubmed: 32321922
Microbiome. 2017 Feb 1;5(1):14
pubmed: 28143587
NPJ Biofilms Microbiomes. 2021 Aug 9;7(1):66
pubmed: 34373464
ISME J. 2017 Dec;11(12):2639-2643
pubmed: 28731476
PLoS One. 2015 Sep 14;10(9):e0137429
pubmed: 26367776
Allergy Asthma Immunol Res. 2020 Feb;12(2):322-337
pubmed: 32009325
Ecology. 2012 Dec;93(12):2533-47
pubmed: 23431585
Front Microbiol. 2020 Aug 26;11:2029
pubmed: 32983030
Gut. 2017 Jan;66(1):70-78
pubmed: 26408641
Biomed Khim. 2014 May-Jun;60(3):281-94
pubmed: 25019391
Educ Psychol Meas. 2021 Aug;81(4):617-643
pubmed: 34262222
Sci Rep. 2022 Apr 5;12(1):5683
pubmed: 35383237
BMC Microbiol. 2021 Mar 31;21(1):98
pubmed: 33789570
BMC Bioinformatics. 2011 Mar 17;12:77
pubmed: 21414208
Microbiol Immunol. 2002;46(8):535-48
pubmed: 12363017
FEMS Microbiol Rev. 2014 Sep;38(5):996-1047
pubmed: 24861948
Eur J Clin Nutr. 2022 Apr;76(4):489-501
pubmed: 34584224
Qual Quant. 2018;52(1):313-354
pubmed: 29416184
Front Immunol. 2020 Jun 09;11:906
pubmed: 32582143
Front Microbiol. 2019 Sep 04;10:1947
pubmed: 31551944
Inflamm Bowel Dis. 2016 Dec;22(12):2802-2810
pubmed: 27824645
J Immunol Res. 2019 Oct 27;2019:7546047
pubmed: 31772949

Auteurs

Hidetaka Tokuno (H)

Symbiosis Solutions Inc., Tokyo, Japan.

Tatsuya Itoga (T)

Symbiosis Solutions Inc., Tokyo, Japan.

Jumpei Kasuga (J)

Symbiosis Solutions Inc., Tokyo, Japan.

Kana Okuma (K)

Symbiosis Solutions Inc., Tokyo, Japan.

Kazumi Hasuko (K)

Symbiosis Solutions Inc., Tokyo, Japan.

Hiroaki Masuyama (H)

Symbiosis Solutions Inc., Tokyo, Japan.

Yoshimi Benno (Y)

Benno Institute for Gut Microflora, Saitama, Japan.

Classifications MeSH